Genmab A/S Stock

Genmab A/S Documents

Documents

0

Ticker

GMAB.CO

ISIN

DK0010272202

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Genmab A/S SEC Filings

Type
Report
Date
No documents available

Genmab A/S Documents 2026

This page contains all official documents and SEC filings for Genmab A/S stock (GMAB.CO, ISIN: DK0010272202). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Genmab A/S's regulatory filings.

Genmab A/S Stock analysis

Genmab A/S Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark.